**Core Concept**
Hairy cell leukemia (HCL) is a rare, chronic, and incurable hematological malignancy characterized by the accumulation of abnormal B lymphocytes in the bone marrow, spleen, and liver. It is a type of non-Hodgkin's lymphoma that predominantly affects middle-aged males.

**Why the Correct Answer is Right**
The correct answer states that hairy cell leukemia results from an expansion of neoplastic T-lymphocytes, which is incorrect. HCL is actually caused by the proliferation of neoplastic B lymphocytes. These abnormal B cells are characterized by their distinctive "hairy" appearance due to the presence of long, hair-like projections on their surface. The exact pathogenesis of HCL is not well understood, but it involves a complex interplay of genetic mutations, epigenetic alterations, and immune system dysregulation.

**Why Each Wrong Option is Incorrect**
**Option A:** Splenomegaly is indeed a common feature of hairy cell leukemia, often presenting as a palpable spleen or hepatosplenomegaly on imaging studies. The spleen is frequently involved, leading to its enlargement.
**Option C:** Taarate Resistant Acid phosphatase (TRAP) is a characteristic enzymatic marker expressed by hairy cell leukemia cells. This enzyme is used as a diagnostic tool to confirm the presence of HCL.
**Option D:** CD25, also known as interleukin-2 receptor alpha chain, is consistently expressed by hairy cell leukemia cells. This makes CD25 a useful marker for identifying these neoplastic B cells.

**Clinical Pearl / High-Yield Fact**
Hairy cell leukemia is often associated with a distinctive clinical triad: splenomegaly, pancytopenia, and a "hairy" appearance of the abnormal B cells on histopathological examination. This triad can help clinicians suspect HCL in patients with a compatible clinical presentation.

**✓ Correct Answer: B. Results from an expansion of neoplastic T-lymphocytes.**